GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JETEMA Co Ltd (XKRX:216080) » Definitions » EV-to-EBIT

JETEMA Co (XKRX:216080) EV-to-EBIT : 17.41 (As of May. 21, 2024)


View and export this data going back to 2019. Start your Free Trial

What is JETEMA Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, JETEMA Co's Enterprise Value is ₩383,342 Mil. JETEMA Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩22,021 Mil. Therefore, JETEMA Co's EV-to-EBIT for today is 17.41.

The historical rank and industry rank for JETEMA Co's EV-to-EBIT or its related term are showing as below:

XKRX:216080' s EV-to-EBIT Range Over the Past 10 Years
Min: -170.76   Med: 9.91   Max: 947.48
Current: 27.51

During the past 8 years, the highest EV-to-EBIT of JETEMA Co was 947.48. The lowest was -170.76. And the median was 9.91.

XKRX:216080's EV-to-EBIT is ranked worse than
74.94% of 427 companies
in the Biotechnology industry
Industry Median: 10.09 vs XKRX:216080: 27.51

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. JETEMA Co's Enterprise Value for the quarter that ended in Mar. 2024 was ₩248,813 Mil. JETEMA Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩22,021 Mil. JETEMA Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 8.85%.


JETEMA Co EV-to-EBIT Historical Data

The historical data trend for JETEMA Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JETEMA Co EV-to-EBIT Chart

JETEMA Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial -16.00 -48.21 23.69 27.89 26.00

JETEMA Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.56 -71.83 -48.90 26.00 -

Competitive Comparison of JETEMA Co's EV-to-EBIT

For the Biotechnology subindustry, JETEMA Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JETEMA Co's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, JETEMA Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where JETEMA Co's EV-to-EBIT falls into.



JETEMA Co EV-to-EBIT Calculation

JETEMA Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=383342.333/22020.976
=17.41

JETEMA Co's current Enterprise Value is ₩383,342 Mil.
JETEMA Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩22,021 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JETEMA Co  (XKRX:216080) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

JETEMA Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=22020.976/248812.768
=8.85 %

JETEMA Co's Enterprise Value for the quarter that ended in Mar. 2024 was ₩248,813 Mil.
JETEMA Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩22,021 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JETEMA Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of JETEMA Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


JETEMA Co (XKRX:216080) Business Description

Traded in Other Exchanges
N/A
Address
1283-4, Gagok-ri, Jijeong-myeon, Gangwon-do, Wonju, KOR
JETEMA Co Ltd is a bio venture company. It offers products such as Botulinum toxin, Filler, Anti-aging solutions. The company also offers medical devices and cosmetics.

JETEMA Co (XKRX:216080) Headlines

No Headlines